Mario Castro
#152,485
Most Influential Person Now
Researcher ORCID: 0000-0001-6328-8994
Mario Castro's AcademicInfluence.com Rankings
Mario Castrocomputer-science Degrees
Computer Science
#8123
World Rank
#8544
Historical Rank
Computational Linguistics
#1754
World Rank
#1772
Historical Rank
Machine Learning
#3232
World Rank
#3271
Historical Rank
Artificial Intelligence
#3539
World Rank
#3589
Historical Rank
Download Badge
Computer Science
Mario Castro's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mario Castro Influential?
(Suggest an Edit or Addition)Mario Castro's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (2013) (2784)
- Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. (2010) (1822)
- Dupilumab Efficacy and Safety in Moderate‐to‐Severe Uncontrolled Asthma (2018) (1009)
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. (2015) (895)
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. (2007) (876)
- Meta-analysis of Genome-wide Association Studies of Asthma In Ethnically Diverse North American Populations (2011) (772)
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial (2016) (713)
- Efficacy and Safety of Dupilumab in Glucocorticoid‐Dependent Severe Asthma (2018) (654)
- Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. (2011) (613)
- Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. (2010) (605)
- Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. (2011) (551)
- Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease (2008) (517)
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma. (2010) (509)
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. (2014) (426)
- Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. (2011) (405)
- COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids (2020) (346)
- Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. (2016) (326)
- Obesity and asthma: an association modified by age of asthma onset. (2011) (319)
- Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline (2019) (307)
- Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations (2016) (299)
- Severe asthma in adults: what are the important questions? (2007) (293)
- Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. (2008) (286)
- Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. (2013) (282)
- Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. (2008) (273)
- Efficacy of esomeprazole for treatment of poorly controlled asthma. (2009) (272)
- Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. (2010) (269)
- Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. (2011) (266)
- Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. (2006) (263)
- Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. (2014) (262)
- A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. (2009) (261)
- The relationship between school absence, academic performance, and asthma status. (2008) (241)
- Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction (2018) (241)
- Asthma status and severity affects missed school days. (2006) (237)
- Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. (2014) (233)
- Determinants of asthma after severe respiratory syncytial virus bronchiolitis. (2012) (229)
- Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. (2008) (227)
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. (2015) (226)
- Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. (2012) (221)
- Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. (1999) (218)
- Epithelial cell proliferation contributes to airway remodeling in severe asthma. (2007) (217)
- Role of Biologics in Asthma (2019) (208)
- Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment (2017) (202)
- Asthma outcomes: composite scores of asthma control. (2012) (199)
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial (2009) (192)
- Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. (2012) (189)
- The safety of inactivated influenza vaccine in adults and children with asthma. (2001) (187)
- Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. (2017) (186)
- Randomized comparison of strategies for reducing treatment in mild persistent asthma. (2007) (179)
- Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. (2012) (174)
- Interleukin 12 P40 Production by Barrier Epithelial Cells during Airway Inflammation (2001) (172)
- Severity of Respiratory Syncytial Virus Bronchiolitis Is Affected by Cigarette Smoke Exposure and Atopy (2005) (170)
- Mechanisms of Remodeling in Asthmatic Airways (2012) (149)
- Asthma intervention program prevents readmissions in high healthcare users. (2003) (141)
- An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. (2013) (141)
- Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. (2012) (140)
- KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma (2017) (136)
- A trial of clarithromycin for the treatment of suboptimally controlled asthma. (2010) (135)
- Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids (2018) (126)
- Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma (2018) (125)
- Importance of hedgehog interacting protein and other lung function genes in asthma. (2011) (125)
- Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. (2010) (123)
- Alterations of the arginine metabolome in asthma. (2008) (122)
- Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. (2008) (122)
- Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT. (2015) (121)
- Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. (2002) (121)
- Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. (2009) (119)
- Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. (2015) (113)
- Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma (2019) (111)
- IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression (2007) (111)
- Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. (2007) (110)
- Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma. (2017) (109)
- Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. (2013) (108)
- Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity (2011) (108)
- Lung imaging in asthmatic patients: the picture is clearer. (2011) (104)
- Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells (1993) (104)
- Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma. (2020) (104)
- Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. (2004) (99)
- Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. (2014) (98)
- BMAL1 LINKS THE CIRCADIAN CLOCK TO VIRAL AIRWAY PATHOLOGY AND ASTHMA PHENOTYPES (2017) (98)
- The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? (1996) (97)
- Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo (1998) (97)
- Risk Factors for Asthma Morbidity and Mortality in a Large Metropolitan City (2001) (97)
- Predictors of response to tiotropium versus salmeterol in asthmatic adults. (2013) (96)
- Sleep quality and asthma control and quality of life in non-severe and severe asthma (2012) (94)
- Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. (2011) (93)
- Predicting episodes of poor asthma control in treated patients with asthma. (2006) (91)
- Resistance to Fas-mediated T cell apoptosis in asthma. (1999) (90)
- Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. (2014) (88)
- Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. (2019) (84)
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. (2019) (82)
- Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma (2017) (81)
- Impact of race on asthma treatment failures in the asthma clinical research network. (2011) (80)
- Investigative bronchoprovocation and bronchoscopy in airway diseases. (2005) (80)
- Quantitative computed tomographic imaging–based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes (2017) (78)
- Registration-based assessment of regional lung function via volumetric CT images of normal subjects vs. severe asthmatics. (2013) (78)
- Asthma Is More Severe in Older Adults (2015) (78)
- Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. (2013) (78)
- Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components (1994) (73)
- Bacterial biogeography of adult airways in atopic asthma (2018) (73)
- Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. (2012) (69)
- The upper-airway microbiota and loss of asthma control among asthmatic children (2019) (69)
- Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived Cytokines (2010) (68)
- Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. (2014) (68)
- Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. (2014) (68)
- IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. (2007) (67)
- Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. (1994) (66)
- Safety of investigative bronchoscopy in the Severe Asthma Research Program. (2011) (66)
- Determinants of exhaled breath condensate pH in a large population with asthma. (2011) (65)
- Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. (2020) (65)
- Natural killer cell–mediated inflammation resolution is disabled in severe asthma (2017) (65)
- Could asthma be worsened by stimulating the T-helper type 1 immune response? (2000) (62)
- Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma (2018) (61)
- Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium‐3 MRI (2010) (60)
- Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. (2004) (60)
- Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma. (2016) (60)
- Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. (2014) (58)
- Quantitative assessment of multiscale structural and functional alterations in asthmatic populations. (2015) (57)
- Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. (2019) (54)
- A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genes. (2014) (52)
- Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012 (2016) (52)
- Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. (1993) (51)
- Cytokine response after severe respiratory syncytial virus bronchiolitis in early life. (2008) (51)
- Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: which is better? (2007) (51)
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma (2010) (51)
- Using imaging as a biomarker for asthma (2017) (50)
- Lower levels of plasmacytoid dendritic cells in peripheral blood are associated with a diagnosis of asthma 6 yr after severe respiratory syncytial virus bronchiolitis (2009) (50)
- Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans (2010) (49)
- Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone (2008) (48)
- Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research Program. (2010) (47)
- Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. (2019) (47)
- Income is an independent risk factor for worse asthma outcomes (2016) (47)
- Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. (2021) (46)
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. (2015) (46)
- Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma (2014) (45)
- Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III. (2016) (45)
- Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis. (2019) (44)
- Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease (2007) (43)
- Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety (2020) (42)
- Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent. (2019) (42)
- Imaging Pulmonary Inducible Nitric Oxide Synthase Expression with PET (2015) (41)
- Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma (2015) (41)
- Longitudinal changes in airway remodeling and air trapping in severe asthma. (2014) (40)
- Improved CT-based estimate of pulmonary gas trapping accounting for scanner and lung-volume variations in a multicenter asthmatic study. (2014) (40)
- Predicting worsening asthma control following the common cold (2008) (40)
- Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort (2018) (40)
- Assessment of regional lung function with multivolume (1)H MR imaging in health and obstructive lung disease: comparison with (3)He MR imaging. (2014) (40)
- How cytokines co-occur across asthma patients: From bipartite network analysis to a molecular-based classification (2011) (38)
- A Pragmatic Trial of Symptom-Based Inhaled Corticosteroid Use in African-American Children with Mild Asthma. (2019) (38)
- Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. (2011) (38)
- A Program to Change the Approach to Care of Children with Asthma in the Primary Care Setting Did Not Reduce Rates of Hospital Admissions: Lessons Learned from a Descriptive Study (2008) (38)
- The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. (2012) (36)
- Vitamin D Supplementation and the Risk of Colds in Patients with Asthma. (2016) (36)
- Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation (2021) (36)
- Volumetric Measurements of Lung Nodules with Multi-Detector Row CT: Effect of Changes in Lung Volume (2006) (36)
- Experimental evidence of age-related adaptive changes in human acinar airways. (2016) (35)
- Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma With Self-reported Chronic Rhinosinusitis. (2020) (35)
- The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma. (2011) (35)
- Bronchial thermoplasty: a novel technique in the treatment of severe asthma (2010) (34)
- Vitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus Bronchiolitis Among Hospitalized Infants. (2015) (33)
- Asthma Friendly Pharmacies: A Model to Improve Communication and Collaboration among Pharmacists, Patients, and Healthcare Providers (2011) (33)
- IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. (2006) (33)
- Severe asthma during childhood and adolescence: A longitudinal study. (2019) (32)
- Azithromycin therapy during respiratory syncytial virus bronchiolitis: Upper airway microbiome alterations and subsequent recurrent wheeze. (2016) (31)
- Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials. (2020) (31)
- A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation. (2013) (30)
- Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program. (2014) (30)
- Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling (2017) (30)
- Cost effectiveness of bronchial thermoplasty in patients with severe uncontrolled asthma (2015) (30)
- Community Asthma Program Improves Appropriate Prescribing in Moderate to Severe Asthma (2005) (29)
- Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects. (2012) (29)
- Obesity's effect on asthma extends to diagnostic criteria (2017) (28)
- Disconnect between sputum neutrophils and other measures of airway inflammation in asthma (2013) (28)
- Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways. (2020) (28)
- Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma. (2017) (27)
- Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. (2020) (27)
- Immune responses to self-antigens in asthma patients: clinical and immunopathological implications. (2012) (27)
- Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials. Bridging Clinical and Patient Perspectives (2019) (27)
- Evaluation and management of severe asthma. (2007) (26)
- Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma (2020) (26)
- Control of epithelial immune-response genes and implications for airway immunity and inflammation. (1998) (25)
- Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity (2014) (25)
- HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma (2020) (24)
- Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. (2009) (24)
- Differentiation of quantitative CT imaging phenotypes in asthma versus COPD (2017) (24)
- Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program. (2021) (23)
- ALX receptor ligands define a biochemical endotype for severe asthma. (2017) (23)
- Nonpharmacologic Therapy for Severe Persistent Asthma. (2017) (22)
- Bronchial Thermoplasty: A Decade of Experience: State of the Art. (2019) (22)
- Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial (2019) (22)
- Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes (1996) (22)
- Vitamin D and asthma: current perspectives (2015) (21)
- The role of viral respiratory infections in the pathogenesis and exacerbation of asthma. (2003) (21)
- Exacerbation-Prone Asthma in the Context of Race and Ancestry in Asthma Clinical Research Network Trials. (2019) (21)
- Investigation of the relationship between IL-6 and type 2 biomarkers in severe asthma. (2019) (20)
- Single-Session Bronchial Thermoplasty Guided by 129Xe Magnetic Resonance Imaging: A Pilot Randomized Clinical Trial. (2020) (20)
- Bronchial thermoplasty: A new treatment for severe refractory asthma (2011) (20)
- ALX receptor ligands define a biochemical endotype for severe asthma. (2018) (20)
- Treatment and prophylaxis of Pneumocystis carinii pneumonia. (1998) (18)
- Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. (2019) (18)
- Variability of methacholine bronchoprovocation and the effect of inhaled corticosteroids in mild asthma. (2014) (18)
- Baseline sputum eosinophil+neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) Cohort. (2020) (18)
- Harmonized outcome measures for use in asthma patient registries and clinical practice. (2019) (17)
- Differences in Particle Deposition Between Members of Imaging-Based Asthma Clusters. (2019) (17)
- Candida albicans Stimulates Arachidonic AcidLiberation from Alveolar Macrophages through ao-Mannan and 1-Glucan CellWallComponents (1994) (17)
- Point: efficacy of bronchial thermoplasty for patients with severe asthma. Is there sufficient evidence? Yes. (2011) (17)
- Bronchial thermoplasty: a novel therapy for severe asthma. (2013) (17)
- PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment. (2021) (16)
- Targeted Molecular Therapies in Allergy and Rhinology (2020) (16)
- Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2) (2021) (16)
- Corrections. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. (2015) (16)
- Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: results from SARP-3. (2021) (16)
- Severe asthma: What makes it so hard to manage? (2009) (15)
- Asthma outcomes from bronchial thermoplasty in the AIR2 trial. (2011) (15)
- Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. (2017) (15)
- Safety of reslizumab in uncontrolled asthma with eosinophilia: a pooled analysis from six trials. (2020) (15)
- Heterogeneity of Severe Asthma in Childhood: Confirmation by Cluster Analysis of Children in the NIH/NHLBI Severe Asthma Research Program (SARP) (2011) (14)
- Selection of controls in clinical trials: introduction and conference summary. (2007) (14)
- Benefits of Airway Androgen Receptor Expression in Human Asthma. (2021) (14)
- Severe Asthma Research Program - Phenotyping and Quantification of Severe Asthma (2009) (14)
- Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma (2019) (14)
- Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium (2020) (14)
- The effect of BPIFA1/SPLUNC1 genetic variation on its expression and function in asthmatic airway epithelium. (2019) (14)
- Associations between household air pollution and reduced lung function in women and children in rural southern India (2018) (14)
- P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. (2013) (14)
- Development and Initial Validation of the Asthma Severity Scoring System (ASSESS). (2020) (13)
- Critical Review of Bronchial Thermoplasty: Where Should It Fit into Asthma Therapy? (2014) (13)
- The impact of self‐identified race on epidemiologic studies of gene expression (2011) (12)
- An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19 (2021) (12)
- Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis? (2015) (12)
- Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history. (2019) (12)
- Lumen area change (Delta Lumen) between inspiratory and expiratory multidetector computed tomography as a measure of severe outcomes in asthmatic patients (2018) (12)
- Recurrent wheezing in children following human metapneumovirus infection. (2018) (12)
- The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma. (2022) (11)
- Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers (2019) (10)
- Strategic plan for pediatric respiratory diseases research: An NHLBI working group report (2009) (10)
- Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. (2016) (10)
- Effect of Reducing Field of View on Multidetector Quantitative Computed Tomography Parameters of Airway Wall Thickness in Asthma (2015) (10)
- Risk Factors for Montelukast Treatment Failure in Step-Down Therapy for Controlled Asthma (2011) (9)
- Lung function trajectories and bronchial hyperresponsiveness during childhood following severe RSV bronchiolitis in infancy (2020) (9)
- Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy (2015) (9)
- Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty. (2019) (9)
- Asthma Bridge: The Asthma Biorepository For Integrative Genomic Exploration (2011) (9)
- Bronchial thermoplasty: ready for prime time--the evidence is there! (2015) (9)
- The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations (2020) (9)
- Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST (2018) (9)
- Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma. (2018) (8)
- Can computed tomography help us identify asthmatic phenotypes? (2014) (8)
- Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate to Severe Asthma. (2020) (8)
- Plasma IL6 levels, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts (2016) (8)
- The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions (2021) (8)
- Clinical significance of the bronchodilator response in children with severe asthma (2019) (8)
- A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge (2013) (8)
- Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2019 (2020) (8)
- The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study (2018) (8)
- Near-fatal asthma: what have we learned? (2002) (8)
- Targeted Bronchial Thermoplasty Guided by 129Xe MRI (2019) (7)
- Bronchial Thermoplasty. (2019) (7)
- Precision Medicine in Asthma-Using Phenotypes to Understand Endotypes That Lead Us to New Therapeutic Options. (2020) (7)
- Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. (2018) (6)
- Impaired tumor necrosis factor‐α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze (2020) (6)
- The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children (2021) (6)
- Prevention and Treatment of Asthma Exacerbations in Adults. (2021) (6)
- Insights into pediatric asthma with hyperpolarized magnetic resonance imaging of the lung. (2013) (6)
- Geography, generalisability, and susceptibility in clinical trials (2021) (6)
- Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma (2021) (6)
- Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function. (2016) (6)
- Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels: (2014) (6)
- Late-breaking abstract: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma (2014) (5)
- Low CC16 mRNA Expression Levels in Bronchial Epithelial Cells Are Associated with Asthma Severity. (2022) (5)
- Efficacy of Reslizumab in Patients with Poorly Controlled Eosinophilic Asthma: Subgroup Analysis of Patients with Nasal Polyps (2011) (5)
- Predictive Model Of Severe Atopic Asthma Phenotypes Using Interleukin 4/13 Pathway Polymorphisms (2011) (5)
- Predicting response to bronchial thermoplasty in patients with severe uncontrolled asthma: An elusive goal (2018) (5)
- Influenza vaccine in patients with asthma (2006) (5)
- A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma (2018) (5)
- A new measure to assess asthma's effect on quality of life from the patient's perspective (2017) (5)
- Effect of KIT Inhibition by Imatinib on Airway Mast Cells in Patients with Severe Refractory Asthma (KIA) (2017) (5)
- Going Beyond "Bio-markers," Think "Life-markers". (2020) (5)
- Evaluation of the difficult-to-treat severe asthma patient in the clinic (2011) (5)
- Asthma education for the frequent emergency department visitor: does it work? (2006) (5)
- Biomarkers of type 2 airway inflammation as predictors of loss of asthma control during step-down therapy for well-controlled disease: The Long Acting Beta Agonist Step-down Study (LASST). (2020) (4)
- The effect of dupilumab on lung function parameters in patients with oral corticosteroid-dependent severe asthma (2020) (4)
- Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in corticosteroid (CS)-dependent severe asthma patients in LIBERTY ASTHMA VENTURE (2018) (4)
- DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY (2018) (4)
- Two-Year Persistence of Effect of Bronchial Thermoplasty (BT) in Patients With Severe Asthma: AIR2 Trial (2010) (4)
- Dupilumab Improves Asthma Control and Asthma-Related Quality of Life in Uncontrolled Persistent Asthma Patients Across All Baseline Exacerbation Rates (2017) (4)
- Use of the Asthma Control Questionnaire by the Asthma Clinical Research Network (2011) (4)
- Treatment for severe eosinophilic asthma—consistent effect of anti-interleukin-5 antibodies? (2016) (4)
- Efficacy of Bronchial Thermoplasty (BT) in Patients with Severe Asthma: The AIR2 Trial. (2009) (4)
- Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma (2021) (4)
- DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY (2018) (4)
- Dupilumab Improved Asthma Control in Patients With Uncontrolled, Moderate-to-Severe Asthma, Regardless of Exacerbations in the Previous Year (2019) (4)
- Temporal biological variability in dendritic cells and regulatory T cells in peripheral blood of healthy adults. (2016) (4)
- Glucocorticoids suppress goblet cell metaplasia in natural and experimental asthma (2004) (3)
- The Effect of Aging and Menopause on Asthma Severity in Women (2014) (3)
- LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data (2015) (3)
- Calcium channel blocker reduces airway remodeling-or does it? (2015) (3)
- Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype. (2022) (3)
- Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility (2017) (3)
- Gender effects in the association between airway microbiome and asthma. (2020) (3)
- Development Of 15-Lipoxygenase-1 (15-LOX1) And 15-Lipoxygenase-2 (15-LOX2) As Markers To Stratify Epithelial Versus Macrophage Activities In Chronic Obstructive Lung Diseases (2012) (3)
- Erratum: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (European Respiratory Journal (2014) 43 (343–373) DOI: 10.1183/09031936.00202013) (2018) (3)
- P506 Impact of weight on the efficacy of mepolizumab in patients with severe eosinophilic asthma (2017) (3)
- Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial (2016) (3)
- Measured by Quantitative CT Analysis the Air-Trapping Asthmatic Phenotype as A Multivariate Analysis of Risk Factors for (2009) (3)
- 1 Registration-based Assessment of Regional Lung Function via Volumetric CT Images of 1 Normals vs . Severe Asthmatics 2 (2013) (3)
- Internet‐Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control (2017) (3)
- Bronchial Thermoplasty in Developing Countries: Is It Really Worth It? Authors' reply (2010) (3)
- Erratum. Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity. (2015) (3)
- The Many "Buckets" of Severe Asthma: Moving Toward Personalized Management. (2017) (3)
- Predicting the Response to Bronchial Thermoplasty: The Needier, the Better. (2020) (3)
- Imaging severe asthma (2019) (3)
- Vitamin D Supplementation and the Risk of Colds in Patients with Asthma (2015) (3)
- Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. (2019) (3)
- Higher Volumes, Better Outcomes: The End or Just the Beginning of the Story for Extracorporeal Membrane Oxygenation? (2015) (3)
- What is allergic bronchopulmonary aspergillosis (ABPA) (2014) (3)
- Estimated Ventricular Size, Asthma Severity and Exacerbations: The SARP III Cohort. (2019) (3)
- Intravenous (IV) reslizumab improves asthma control, symptoms, and quality of life in patients with historically elevated blood eosinophils (2018) (2)
- Rare Beta2-Adrenergic Receptor Gene Polymorphisms In Asthma Cases And Controls From The Severe Asthma Research Program (2011) (2)
- Autoamplification of stat 1-dependent gene expression (1998) (2)
- Outcome Reporting in Asthma Research (2011) (2)
- Effect of intranasal corticosteroids on allergic airway disease in asthma. (2017) (2)
- Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 (2016) (2)
- Management of Uncontrolled Asthma: A Framework for Novel and Legacy Biologic Treatments (2022) (2)
- Development Of Clinical Biomarkers To Monitor Innate Immune Abnormalitiies In Chronic Obstructive Lung Disease (2011) (2)
- Asthma in 2016: reassured about the old, excited about the new. (2016) (2)
- Repeatability Of CT Airway Measurements In Severe Asthma (2011) (2)
- Performance of the Asthma Impact on Quality of Life Scale (A‐IQOLS) in diverse asthma research populations and demographic subgroups (2019) (2)
- Bronchial thermoplasty: an update for the interventional pulmonologist (2018) (2)
- Persistent activation of an innate NKT cell-macrophage immune axis that translates respiratory viral infection into chronic lung disease (2008) (2)
- KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma - Impact on Airway Remodeling measured by MDCT (2018) (2)
- Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma (2019) (2)
- Insensitivity to Corticosteroids Predicts Longitudinal Loss of Lung Function in the NHLBI Severe Asthma Research Program (SARP III) (2019) (2)
- Cytokine response after severe RSV bronchiolitis in early life (2008) (2)
- Reslizumab Treatment for Moderate to Severe Asthma with Elevated Blood Eosinophil Levels (2015) (2)
- DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis‐associated variants in the Severe Asthma Research Program (2022) (2)
- Randomized trial to evaluate azithromycin’s effects on serum and upper airway IL-8 levels, and recurrent wheezing in infants with RSV bronchiolitis (2015) (2)
- Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study (2019) (2)
- Bronchial Thermoplasty leads to rapid and persistent improvements in airway remodeling (2019) (2)
- DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATE AND IMPROVES LUNG FUNCTION REGARDLESS OF AGE AT ONSET OF ASTHMA: THE LIBERTY ASTHMA QUEST STUDY (2019) (2)
- Quantitative CT-based image registration metrics provide different ventilation and lung motion patterns in prone and supine positions in healthy subjects (2020) (2)
- Function with Multivolume (2014) (2)
- Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era. (2019) (2)
- Evaluation of Eosinophilic Asthma Patients Without Blood Eosinophil (EOS) Response to Intravenous (IV) Reslizumab in a Post‐Hoc Analysis of 52‐Week Placebo‐Controlled Phase 3 Studies: 292 (2019) (2)
- Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study (2019) (2)
- Increased Nasal Plasmacytoid Dendritic Cells Are Associated with Recurrent Wheezing Following Severe RSV Bronchiolitis (2016) (2)
- Dupilumab effect on asthma control and health-related quality of life in patients with oral corticosteroid-dependent severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps (2019) (2)
- Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma (2022) (1)
- Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST (2021) (1)
- Bronchial thermoplasty: safe for our severe asthma patients? (2013) (1)
- Comparing Two Ways to Manage Asthma in African American Children—The ASIST Study (2020) (1)
- Hospital Collaboration in Response to the COVID-19 Pandemic in Kansas City Metropolitan Region (2021) (1)
- Exposure to Wood Smoke is Associated with Increased Risk of Asthma and Respiratory Symptoms in a Honduran Population (2017) (1)
- Investigation of IL-6 and IL-6R levels as Biomarkers for Asthma Severity and Asthma Exacerbations (2019) (1)
- The emerging role of quantitative imaging in asthma. (2020) (1)
- Long-Term Efficacy and Safety of Bronchial Thermoplasty (BT): 4 Year Follow-Up Results from a Large Scale Prospective Study (2019) (1)
- Smoke Exposure and Atopy Severity of Respiratory Syncytial Virus Bronchiolitis Is Affected by Cigarette (2007) (1)
- LONG-TERM EFFECT OF DUPILUMAB ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 ASTHMA: LIBERTY ASTHMA TRAVERSE STUDY (2021) (1)
- Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function (2020) (1)
- Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma (2019) (1)
- Burden of Persistent Asthma in Patients Treated With Medium- to High-Dose Inhaled Corticosteroids: Baseline Data From a Phase 2 Clinical Trial of Dupilumab (2015) (1)
- Chapter 18 – Imaging Procedures and Bronchial Thermoplasty for Asthma Assessment and Intervention (2018) (1)
- 116 Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases (2012) (1)
- Exacerbation Reduction In Patients Based Upon Baseline Eosinophil Counts and FEV1 Reversibility (2020) (1)
- S31 Dupilumab reduces severe exacerbations across baseline disease characteristics in patients with elevated baseline type 2 biomarkers: the LIBERTY ASTHMA QUEST study (2019) (1)
- Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels (2018) (1)
- Rebuttal to commentary (2014) (1)
- 2020 Updated Asthma Guidelines: Bronchial Thermoplasty in the Management of Asthma. (2021) (1)
- Ventilation Defect Percent from Hyperpolarized Helium-3 MRI Is Predictive of Asthma Exacerbation Severity (2019) (1)
- Bronchial thermoplasty. (2020) (1)
- Features of the Bronchial Bacterial Microbiome Associated with Allergy and Mild Allergic Asthma. (2016) (1)
- Biomarkers to Predict Response to ICS and LAMA in Adolescents and Adults with Mild Persistent Asthma. (2021) (1)
- Chapter 1 – Epidemiology of Asthma (2008) (1)
- Estimated Ventricular Size, Asthma Severity, and Exacerbations The Severe Asthma Research Program III Cohort (2020) (1)
- 2 A nursing perspective on the social challenges and possible solutions for an adult asthma intervention program (2000) (1)
- A Numerical Study of Airway Resistance and Particle Deposition in Normal and Asthmatic Lungs (2012) (1)
- Asthma Management in Adults. (2022) (1)
- IPREDICT: PATIENT EXPERIENCE AND COMPLIANCE WITH DIGITAL TECHNOLOGIES MEASURING UNCONTROLLED ASTHMA EVENTS AND POTENTIAL TRIGGERS IN A 6-MONTH STUDY (2019) (1)
- P59: OMALIZUMAB TO TREAT IDIOPATHIC NON‐HISTAMINERGIC ACQUIRED ANGIOEDEMA (2018) (1)
- Mitochondrial DNA Variation and Severe Asthma (2019) (1)
- Sex effects in the association between airway microbiome and asthma (2021) (1)
- Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL−1 (2022) (1)
- Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose. (2022) (1)
- Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype (2019) (1)
- The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population (2021) (1)
- Tolérance du tiotropium Respimat en traitement additionnel d’un traitement continu par CSI ± LABA chez des patients adultes ayant un asthme symptomatique : analyse des données groupées (2015) (1)
- Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study (2019) (1)
- Urinary total conjugated 3-bromotyrosine, asthma severity and exacerbation risk. (2022) (1)
- Age of Asthma Onset, not Severity, Predicts Environmental Allergy Clusters (2020) (0)
- S49 Dupilumab improves lung function across baseline disease characteristics in patients with evidence of type 2 inflammation at baseline: the LIBERTY ASTHMA QUEST study (2019) (0)
- Evidence-Based Assessment of Bronchial Thermoplasty in Asthma: Mechanisms and Outcomes (2018) (0)
- Peripheral Blood Dendritic Cells In Children Following RSV Bronchiolitis: Initial Results From The RSV Bronchiolitis In Early Life-II (RBEL-II) Study (2011) (0)
- Acinar Structural Changes in Mild COPD Detected By In Vivo Lung Morphometry With Hyperpolarized Helium-3 MRI (2009) (0)
- Effect Of Coexisting Chronic Conditions On Mortality And Morbidity In Adult Asthma (2012) (0)
- DUPILUMAB REDUCES SEVERE EXACERBATIONS IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA WITH AND WITHOUT EARLY IMPROVEMENTS IN LUNG FUNCTION (2019) (0)
- Bronchial thermoplasty - persistence of benefits out to 5 years in patients with severe asthma (2013) (0)
- Age Dependent Differences in Seasonal Versus Perennial Allergen Sensitivity in Association with Severe Asthma (2019) (0)
- Asthma Endotypes: What are the Therapeutic Implications? (2016) (0)
- Predictors of Non-Response to Symptom-Based as-Needed Use of Inhaled Corticosteroids Versus Guideline-Driven Daily Use of ICS in African American Children with Asthma in Primary Care Setting (2020) (0)
- Sputum Eosinophil Peroxidase Identifies a Subset of Asthmatics with Severe Airflow Obstruction and Frequent Exacerbations (2022) (0)
- Longitudinal Study Of Mucin And Structural Changes To The Airway In Severe Asthma (2010) (0)
- Asthma Phenotypes Using Cluster Analysis And MDCT Chest In The Severe Asthma Research Program (SARP) (2010) (0)
- Bronchial thermoplasty effect on ventilation guided by hyperpolarized 129Xe MRI in severe asthma (2019) (0)
- Reply: To PMID 25174863. (2015) (0)
- Azithromycin to Prevent Recurrent Wheeze Following Severe RSV bronchiolitis: The APW-RSV II Clinical Trial (2022) (0)
- Investigations of a combination of atopic status and age of asthma onset identify asthma subphenotypes. (2023) (0)
- Pharmacotherapy and evidence-based medicine (2015) (0)
- Erratum: Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers (2019) (0)
- Chapter 18 – The Goals for Asthma Management: Short and Long Term (2008) (0)
- QUESTION: In children and adults with stable asthma, is the inactivated trivalent split virus influenza vaccine safe? (2002) (0)
- Longitudinal characteristics of the Severe Asthma Research Program (SARP) clinical clusters (2020) (0)
- Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children. (2019) (0)
- Multicohort Meta-Analysis of Bronchial Epithelial Cells Classifies Asthma from Healthy Subjects and Identifies Pathways in Asthma (2022) (0)
- 65 – Lung Imaging (2014) (0)
- Intravenous (IV) reslizumab efficacy does not differ by blood eosinophil lowering to levels above or below 50 cells/µL (2018) (0)
- Longitudinal CT Assessment Of Airway Wall Thickening In Severe Asthma (2011) (0)
- Genetic analyses of chr11p15.5 region identify MUC5AC-MUC5B associated with asthma-related phenotypes. (2023) (0)
- P505 Impact of weight on steroid reduction in patients with severe eosinophilic asthma treated with mepolizumab (2017) (0)
- The Severe Asthma Patient with Eosiniophilic Phenotype Should Always Be Treated with Anti-Interleukin-5 Therapies (2019) (0)
- Applications of Monoclonal Biological Therapy in Asthma (2017) (0)
- with bronchodilation air trapping and incomplete reversal of obstruction Lung function in adults with stable but severe asthma (2015) (0)
- S8-4 Bronchial Thermoplasty : A Novel Treatment for Severe Asthma(The role of airway smooth muscle in pathogenesis asthma) (2012) (0)
- Rebuttal From Dr Shifren et al (2011) (0)
- Peroxidases as Biomarkers of Airway Neutrophilic and Eosinophilic Activation in Asthma (2019) (0)
- Bronchial Mast Cell Markers and Clinical Asthma Severity In Steroid Refractory Asthmatics (2014) (0)
- Validation of Quality of Life Questionnaires in African American Children with Mild Asthma (2019) (0)
- Is Your Patient with Uncontrolled Severe Asthma Not Responding to a Biologic? (2019) (0)
- Dupilumab Efficacy in GINA-Defined Difficult-to-Treat Type 2 Asthma Patients (2020) (0)
- Regional ventilation quantified by multi-volume computed tomography (CT): Comparison with 3-helium magnetic resonance imaging (3He-MRI) (2014) (0)
- Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study (2020) (0)
- DUPILUMAB REDUCES SEVERE OUTPATIENT ASTHMA EXACERBATIONS, CUMULATIVE DOSE, AND TOTAL NUMBER OF DAYS OF SYSTEMIC CORTICOSTEROID USE AMONG PATIENTS WITH MODERATE-TO-SEVERE TYPE-2 ASTHMA (2020) (0)
- Omalizumab in allergic eosinophilic asthma and lung eosinophil numbers: A 78-week randomized controlled trial (2013) (0)
- Dupilumab Efficacy in GINA-Defined Difficult-to-Treat Type 2 Asthma Patients in the LIBERTY ASTHMA QUEST Study (2021) (0)
- Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL (2020) (0)
- Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis (2017) (0)
- Categorization of asthma patients by Global Initiative for Asthma (GINA) 2018 guidelines using a US administrative claims database (2020) (0)
- Characterization of Gut Microbiome in Infants with Severe Respiratory Syncytial Virus Bronchiolitis: 7 (2019) (0)
- Resistance to Fas-Mediated T Cell Apoptosis (1999) (0)
- Effect of Dupilumab on patient-reported breathing and rescue medication use (2020) (0)
- IL4 Imaging in Asthma : The Picture is Clearer (2012) (0)
- Bronchial Thermoplasty for the Treatment of Severe Asthma (2014) (0)
- Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements (2020) (0)
- The Role of Vitamin D in Clinical Asthma (2015) (0)
- Assessment of Effects of Selective Airway Luminal Expansion on Inhaled Particle Deposition in Severe Asthmatic Human Lungs - A Numerical Study (2018) (0)
- CCL5 Release From Upper Airway Epithelial Cells Is Not Associated With Severity Of RSV Bronchiolitis (2011) (0)
- Exacerbation Of Asthma Induced By Corticosteroid Withdrawal Is Not Associated With Airway Remodeling (2010) (0)
- Determinants of Breath Condensate pH in a Large Asthma Cohort: pH as a Potential Biomarker for Identifying Asthma Subpopulations. (2009) (0)
- QCT-based Measures Of Airway Narrowing And Shape Changes Associated With Endobronchial Biopsy Tissue Measures of Airway Remodeling And Clinical Outcomes In Asthma (2021) (0)
- Bronchial Epithelial Cell Transcriptional Responses to Inhaled Corticosteroids Dictate Severe Asthmatic Outcomes. (2023) (0)
- Androgen Metabolism and Severe Asthma: HSD3B1 Genotype Identifies Glucocorticoid Responsiveness (2020) (0)
- Insulin Resistance Is Associated with Longitudinal Decline in Lung Function in the Severe Asthma Research Program (2019) (0)
- Airway Remodeling in Severe Asthma Is Associated with Increased Muc5AC and Decreased Cilia-Related Gene Expression (2020) (0)
- CCL5 is a Potential Bridge Between Type-1 and Type-2 Inflammation in Asthma. (2023) (0)
- Dupilumab treatment effects are observed after the first dose across atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps: Data from Phase 3 SOLO 1 & 2, LIBERTY ASTHMA QUEST, and SINUS-52 Studies (2020) (0)
- Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium (2021) (0)
- Guideline Recommendations and Emerging Treatments for Severe Asthma (2015) (0)
- Biological Variability of Dendritic Cells and Regulatory T Cells in Peripheral Blood of Normal Adults (2015) (0)
- The authors reply [4] (2007) (0)
- Differentiation of Airway Structure and Lung Function in a Korean Asian Vs. White American Cohort Via Quantitative CT-Based Variables (2019) (0)
- DNA Sequencing Analysis of Cystic Fibrosis Transmembrane Regulator Gene Identifies Cystic Fibrosis-Associated Variants in the Severe Asthma Research Program (2022) (0)
- 24 Common and Rare Variation in the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes (2012) (0)
- Bacterial biogeography of adult airways in atopic asthma (2018) (0)
- Fine-Mapping of Bronchodilator Response Admixture Mapping Peak to Identify Causal Drug Response Genetic Variants (2019) (0)
- High Healthcare Utilization in a Severe Asthma Population Despite Use of High Dose ICS/LABA. (2009) (0)
- Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium Measures In COPD Study (SPIROMICS), (2020) (0)
- Deep Resequencing of the Beta-2 Adrenergic Receptor Gene (ADRB2) in COPD and Asthma Cohorts Identifies Functional Rare Variants (2020) (0)
- Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE (2022) (0)
- Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction (2022) (0)
- Dupilumab Reduces Exacerbations And Improves Lung Function Regardless Of Prior Asthma Exacerbation Status: LIBERTY ASTHMA TRAVERSE Open-Label Extension Study (2023) (0)
- A Phase IIa, Double-Blinded, Randomized Placebo-Controlled Trial of MAPKAPK2 Inhibition by ATI-450 in Treatment of Moderate-Severe COVID-19 Pneumonia (2021) (0)
- Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction. (2022) (0)
- Low Airway Deoxyribonuclease-1 Activity in Eosinophilic Asthma (2022) (0)
- WHY, WHEN, AND HOW? OPTIMISING THE MANAGEMENT OF PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA (2016) (0)
- Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation (2022) (0)
- Gastroesophageal Reflux Predicts Asthma Exacerbations in Obese Asthmatics (2019) (0)
- Persistent Mucus Plugs in Asthma Associate with Changes in Airflow Over Time (2022) (0)
- Sputum Mast Cells and Eosinophils Identify Asthmatics with Lower Lung Function and Proneness to Exacerbations (2018) (0)
- Dupilumab Reduced Oral Corticosteroid Use in Patients with OCS-Dependent Severe Asthma Consistently Across Baseline Disease Characteristics in the Phase 3 LIBERTY ASTHMA VENTURE Study (2020) (0)
- Automated Reconstruction of 3D Models of Airway Mucus Plugs to Inform Machine Learning-Based Methods for Mucus Plug Scoring in Asthma (2020) (0)
- Toward Extended Quantitative CT Imaging Application with Deep Transfer Learning (0)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECT OF DUPILUMAB ON AIRWAY REMODELING IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: THE VESTIGE STUDY (2021) (0)
- Evidence for Upregulation of Innate Immunity Type1 Cytokines in Bronchoalveolar Lavage Fluid from Subjects with Severe Asthma on Daily Oral Corticosteroids in the Severe Asthma Research Program (SARP) (2020) (0)
- Bronchial Thermoplasty : A new treatment for severe asthma (2012) (0)
- Predictors Of Airway Remodeling And Decline In Lung Function In Severe Asthma (2012) (0)
- Predictors of Asthma Exacerbations in Th2 High vs. Th2 Low Patients (2019) (0)
- Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE (2022) (0)
- Comprar Clinical Asthma | Monica Kraft | 9780323042895 | Mosby (2008) (0)
- Against the ATS statement on human embryonic stem cell research. (2006) (0)
- Quantitative Analysis of Mucus Plugs in Computed Tomography (CT) Lung Scans from Patients with Severe Asthma Reveals Heterogeneous Mucus Plug Phenotypes and Enables Automation via Deep Learning Approaches (2022) (0)
- Quantitative CT Imaging in Adults with Asthma Can Predict Both Future Lung Function Decline and Asthma Morbidity: Results from the SARP III Study (2020) (0)
- Quantitative CT Analysis of Ambient Particulate Matter Exposure-Associated Multiscale Structure and Function Alteration in Asthma, COPD, and IPF Lungs (2022) (0)
- DUPILUMAB IMPROVES LUNG FUNCTION IN PATIENTS IRRESPECTIVE OF ON-STUDY ASTHMA EXACERBATIONS (2020) (0)
- Variability Of Provocative Concentration Of Methacholine Causing A 20% Drop In FEV1 (PC20) Over Time In Asthmatics On A Stable Dose Of Inhaled Corticosteroid (2011) (0)
- Analysis of Airway Type-2 Inflammation and Vitamin D Supplementation in Asthma (2020) (0)
- Baseline Quantitative Computed Tomography Measures of Skeletal Muscle Adiposity and Lung Function Trajectory in the Severe Asthma Research Program (2021) (0)
- Skeletal Muscle Adiposity and Lung Function Trajectory in the Severe Asthma Research Program (SARP). (2022) (0)
- Cluster-Guided Image Matching Analysis of Multiscale Lung Response to Bronchial Thermoplasty (2019) (0)
- Exacerbation Risk and Type 2 Inflammation in Placebo Patients During a Phase 2b Study of Dupilumab in Patients With Uncontrolled Persistent Asthma (2018) (0)
- Predictors of inhaled corticosteroid taper failure in adults with asthma. (2019) (0)
- Cytokine Response Post Severe RSV Bronchiolitis Does Not influence Lung Function--Results From The RSV Bronchiolitis In Early Life (RBEL) Study (2010) (0)
- When Is It Time for Bronchial Thermoplasty (2018) (0)
- Erratum: Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma (2019) (0)
- Type 2 Inflammation in the Sputum of Adolescents with Asthma. (2020) (0)
- Meta-Analyses Of Genome-Wide Association Studies In Five Asthma Populations Identify Novel Genes Associated With Lung Function (2011) (0)
- Immunologic development early in life following severe respiratory syncytial virus (RSV) bronchiolitis (2004) (0)
- Challenges of Medically Severe Asthmatic Patients (2017) (0)
- Does Azithromycin Modify Viral Load During Severe RSV Bronchiolitis ? (2015) (0)
- a large asthma population Determinants of exhaled breath condensate pH in (2010) (0)
- Impaired Glucose Metabolism Is Associated with Asthma Severity in the Severe Asthma Research Program-3 (SARP-3) Cohort (2019) (0)
- Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control (2019) (0)
- Risk Factors Associated With Bronchiolitis in Puerto Rican Children (2020) (0)
- Does Vitamin D Have a Role in Clinical Asthma (2014) (0)
- Bronchial Th ermoplasty (2017) (0)
- Benralizumab: Not Just for Your Poorly Controlled Asthmatic (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mario Castro?
Mario Castro is affiliated with the following schools:
